460 related articles for article (PubMed ID: 17827948)
1. Almost all irritable bowel syndromes are post-infectious and respond to probiotics: consensus issues.
Cuomo R; Savarese MF; Gargano R
Dig Dis; 2007; 25(3):241-4. PubMed ID: 17827948
[TBL] [Abstract][Full Text] [Related]
2. Almost all irritable bowel syndromes are post-infectious and respond to probiotics: controversial issues.
Barbara G; Stanghellini V; Cremon C; De Giorgio R; Corinaldesi R
Dig Dis; 2007; 25(3):245-8. PubMed ID: 17827949
[TBL] [Abstract][Full Text] [Related]
3. Review article: probiotics and prebiotics in irritable bowel syndrome.
Spiller R
Aliment Pharmacol Ther; 2008 Aug; 28(4):385-96. PubMed ID: 18532993
[TBL] [Abstract][Full Text] [Related]
4. Postinfectious irritable bowel syndrome.
Barbara G; Cremon C; Pallotti F; De Giorgio R; Stanghellini V; Corinaldesi R
J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S95-7. PubMed ID: 19300138
[TBL] [Abstract][Full Text] [Related]
5. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.
Camilleri M
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S123-5. PubMed ID: 18806702
[TBL] [Abstract][Full Text] [Related]
6. [Post-infectious irritable bowel syndrome. A review based on current evidence].
Gómez-Escudero O; Schmulson-Wasserman MJ; Valdovinos-Díaz MA
Rev Gastroenterol Mex; 2003; 68(1):55-61. PubMed ID: 12940101
[TBL] [Abstract][Full Text] [Related]
7. Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis.
Villani AC; Lemire M; Thabane M; Belisle A; Geneau G; Garg AX; Clark WF; Moayyedi P; Collins SM; Franchimont D; Marshall JK
Gastroenterology; 2010 Apr; 138(4):1502-13. PubMed ID: 20044998
[TBL] [Abstract][Full Text] [Related]
8. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
[TBL] [Abstract][Full Text] [Related]
9. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors.
Lee KJ; Kim YB; Kim JH; Kwon HC; Kim DK; Cho SW
J Gastroenterol Hepatol; 2008 Nov; 23(11):1689-94. PubMed ID: 19120860
[TBL] [Abstract][Full Text] [Related]
10. [Post-infectious irritable bowel syndrome].
Serghini M; Karoui S; Boubaker J; Filali A
Tunis Med; 2012 Mar; 90(3):205-13. PubMed ID: 22481191
[TBL] [Abstract][Full Text] [Related]
11. The rationale and clinical effectiveness of probiotics in irritable bowel syndrome.
Ringel Y; Ringel-Kulka T
J Clin Gastroenterol; 2011 Nov; 45 Suppl():S145-8. PubMed ID: 21992954
[TBL] [Abstract][Full Text] [Related]
12. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.
Quigley EM; Flourie B
Neurogastroenterol Motil; 2007 Mar; 19(3):166-72. PubMed ID: 17300285
[TBL] [Abstract][Full Text] [Related]
13. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
[TBL] [Abstract][Full Text] [Related]
14. Disease burden of post-infectious irritable bowel syndrome in The Netherlands.
Haagsma JA; Siersema PD; De Wit NJ; Havelaar AH
Epidemiol Infect; 2010 Nov; 138(11):1650-6. PubMed ID: 20223049
[TBL] [Abstract][Full Text] [Related]
15. Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome.
Brenner DM; Chey WD
Rev Gastroenterol Disord; 2009; 9(1):7-15. PubMed ID: 19367213
[TBL] [Abstract][Full Text] [Related]
16. Post-infectious irritable bowel syndrome: the past, the present and the future.
Ghoshal UC; Ranjan P
J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():94-101. PubMed ID: 21443719
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a risk score for post-infectious irritable bowel syndrome.
Thabane M; Simunovic M; Akhtar-Danesh N; Marshall JK
Am J Gastroenterol; 2009 Sep; 104(9):2267-74. PubMed ID: 19568228
[TBL] [Abstract][Full Text] [Related]
18. Irritable bowel syndrome - The role of complementary medicines in treatment.
Pirotta M
Aust Fam Physician; 2009 Dec; 38(12):966-8. PubMed ID: 20369148
[TBL] [Abstract][Full Text] [Related]
19. [Post-infectious irritable bowel syndrome].
Pallotti F; Fogacci E; Frisoni C; Serra M; Bellacosa L; Carini G; Cremon C; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G
Clin Ter; 2011; 162(2):157-61. PubMed ID: 21533323
[TBL] [Abstract][Full Text] [Related]
20. [Postinfectious irritable bowel syndrome].
Döbrönte Z; Lakner L; Sarang K
Orv Hetil; 2006 Oct; 147(43):2077-80. PubMed ID: 17297754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
